COFACE just put Q3 2026 on the table with solid underwriting metrics and a cleaner claims picture, yet the share closed around €15.6, only marginally above its own book value per share of €14.3. The headline is not the income statement. It is the underwriting engine, with a 9‑month net combined ratio at 72.4% and a loss ratio near 37.7%, telling a calmer story than any one day’s price move.
Love COFACE’s disciplined combined ratio but uneasy that the share price is hugging book value this closely? Scan the 195 high quality undervalued stocks for insurers and financials that pair resilient underwriting profiles with what may be more generous market pricing.
The bullish story hangs on COFACE turning its transformation into measurably better economics, not just slogans.
"Execution of the Power the Core plan, built around data, connectivity and technology, including automation and artificial intelligence driven tools, is creating a differentiated risk platform that can support underwriting quality and potentially help protect earnings and net margins."
Q3 results give that claim some footing. A 9-month net combined ratio at 72.4% against a stated 78% through-the-cycle target signals that underwriting discipline is holding. A loss ratio near 37.7% supports the idea that risk selection remains tight even as claims frequency normalizes. The rising cost ratio shows that the Power the Core spend is visible in expenses, so far matched by resilient margins and a 10.7% RoATE.
The price and this Narrative do not agree. → Uncover what this Narrative says COFACE is actually worth.
The bearish angle argues that COFACE’s push into data and AI could quietly erode profitability through a stubbornly higher cost base.
"If competitors scale faster or new entrants emerge, COFACE may need to keep stepping up investment just to stand still, which could keep the cost ratio elevated and weigh on net margins."
Q3 results give that concern some bite. The net cost ratio is up about 2.4 points year to date even as revenue growth remains modest. Net income excluding extra items for Q3 slipped to €47.7m and basic EPS to €0.32, so the heavier spend is not yet translating into higher quarterly earnings.
COFACE just showed how a cleaner underwriting story does not always translate into an emphatic valuation shift. The real opportunity could sit in companies where fundamentals are changing while prices have not fully adjusted.
Those are three of them. See all 195 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com